Cite
HARVARD Citation
Wang, S. et al. (2020). Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer. Journal for immunotherapy of cancer. 8 (2), p. . [Online].